Fungus analysis funding accounts for less than 3% of the infectious disease budgets of major international funders (at least in the UK and US), which displays the lack of funding purposes submitted. Our capability to deal with fungal diseases is severely hampered by a worldwide lack of scientists and clinicians working on this space. This lack of capacity is especially extreme within the developing world, which suffers the best burden of disease. It is telling that there is not a single vaccine towards fungal infections in present medical use. Worryingly, drug resistance is increasing and th